Abstract
Arteriovenous malformations (AVM) of the brain (also known as pial or parenchymal AVMs) are defined as intracranial space-occupying lesions composed of feeding arteries, draining veins, and a nidus of tangled vessels without an intervening capillary bed. There is no normal interposed brain tissue, but there can be surrounding gliosis. Morphology can vary, but AVMs are typically triangular in shape with the base towards the cortex and the apex towards the ventricular system [Brown et al. Mayo Clin Proc 80(2):269–81, 2005; Winn. Youmans neurological surgery. 6th edn. Elsevier, Philadelphia, PA, 2011; Moftakhar et al. Neurosurg Focus 26(5):E10, 2009]. While much of the pathophysiology, epidemiology, and natural history remain unclear, there has been successful advancement in the understanding and management of these complex lesions, especially with regard to the application of microsurgical, radiosurgical, and endovascular therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Winn HR. Youmans neurological surgery. 6th ed. Philadelphia, PA: Elsevier; 2011.
Moftakhar P, et al. Cerebral arteriovenous malformations. Part 1: cellular and molecular biology. Neurosurg Focus. 2009;26(5):E10.
Vanaman MJ, Hervey-Jumper SL, Maher CO. Pediatric and inherited neurovascular diseases. Neurosurg Clin N Am. 2010;21(3):427–41.
Niazi TN, et al. Diagnosis and management of arteriovenous malformations in children. Neurosurg Clin N Am. 2010;21(3):443–56.
Turjman F, et al. Correlation of the angioarchitectural features of cerebral arteriovenous malformations with clinical presentation of hemorrhage. Neurosurgery. 1995;37(5):856–60. Discussion 860–2.
Brown Jr RD, et al. The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg. 1988;68(3):352–7.
da Costa L, et al. The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke. 2009;40(1):100–5.
Kondziolka D, et al. Cerebral arteriovenous malformations with associated arterial aneurysms: hemodynamic and therapeutic considerations. Can J Neurol Sci. 1988;15(2):130–4.
Moftakhar P, et al. Cerebral arteriovenous malformations. Part 2: physiology. Neurosurg Focus. 2009;26(5):E11.
Kader A, et al. Recurrent cerebral arteriovenous malformations after negative postoperative angiograms. J Neurosurg. 1996;85(1):14–8.
Young WL, et al. Arteriovenous malformation draining vein physiology and determinants of transnidal pressure gradients. The Columbia University AVM Study Project. Neurosurgery. 1994;35(3):389–95. Discussion 395–6.
Brown Jr RD, et al. Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population-based study of intracranial vascular malformations in Olmsted County, Minnesota. J Neurosurg. 1996;85(1):29–32.
Ohaegbulam SC. The epidemiology of brain arteriovenous malformations. Neurosurgery. 2001;49(1):226–8.
Stapf C, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350–5.
Berman MF, et al. The epidemiology of brain arteriovenous malformations. Neurosurgery. 2000;47(2):389–96. Discussion 397.
Al-Shahi R, et al. Prevalence of adults with brain arteriovenous malformations: a community based study in Scotland using capture-recapture analysis. J Neurol Neurosurg Psychiatry. 2002;73(5):547–51.
ApSimon HT, et al. A population-based study of brain arteriovenous malformation: long-term treatment outcomes. Stroke. 2002;33(12):2794–800.
Stapf C, et al. The New York Islands AVM Study: design, study progress, and initial results. Stroke. 2003;34(5):e29–33.
Al-Shahi R, et al. Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke. 2003;34(5):1163–9.
Gabriel RA, et al. Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke. 2010;41(1):21–6.
Stapf C, et al. Epidemiology and natural history of arteriovenous malformations. Neurosurg Focus. 2001;11(5):e1.
Al-Shahi R, Warlow C. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain. 2001;124(Pt 10):1900–26.
Buis DR, et al. Brain arteriovenous malformations: from diagnosis to treatment. J Neurosurg Sci. 2011;55(1):39–56.
Fullerton HJ, et al. Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke. 2005;36(10):2099–104.
Kim H, et al. Racial/ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke. 2007;38(9):2430–7.
Stapf C, et al. Effect of age on clinical and morphological characteristics in patients with brain arteriovenous malformation. Stroke. 2003;34(11):2664–9.
Brown Jr RD, et al. Natural history, evaluation, and management of intracranial vascular malformations. Mayo Clin Proc. 2005;80(2):269–81.
Hernesniemi JA, et al. Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery. 2008;63(5):823–9. Discussion 829–31.
Laakso A, et al. Risk of hemorrhage in patients with untreated Spetzler-Martin grade IV and V arteriovenous malformations: a long-term follow-up study in 63 patients. Neurosurgery. 2011;68(2):372–7. Discussion 378.
Ondra SL, et al. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg. 1990;73(3):387–91.
Graf CJ, Perret GE, Torner JC. Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg. 1983;58(3):331–7.
Kondziolka D, McLaughlin MR, Kestle JR. Simple risk predictions for arteriovenous malformation hemorrhage. Neurosurgery. 1995;37(5):851–5.
Kader A, et al. The influence of hemodynamic and anatomic factors on hemorrhage from cerebral arteriovenous malformations. Neurosurgery. 1994;34(5):801–7. Discussion 807–8.
Arnaout OM, et al. Posterior fossa arteriovenous malformations. Neurosurg Focus. 2009;26(5):E12.
Fleetwood IG, et al. Deep arteriovenous malformations of the basal ganglia and thalamus: natural history. J Neurosurg. 2003;98(4):747–50.
Brown Jr RD, Wiebers DO, Forbes GS. Unruptured intracranial aneurysms and arteriovenous malformations: frequency of intracranial hemorrhage and relationship of lesions. J Neurosurg. 1990;73(6):859–63.
Fults D, Kelly Jr DL. Natural history of arteriovenous malformations of the brain: a clinical study. Neurosurgery. 1984;15(5):658–62.
Choi JH, Mohr JP. Brain arteriovenous malformations in adults. Lancet Neurol. 2005;4(5):299–308.
Mossa-Basha M, Chen J, Gandhi D. Imaging of cerebral arteriovenous malformations and dural arteriovenous fistulas. Neurosurg Clin N Am. 2012;23(1):27–42.
Okada T, et al. Diffusion tensor fiber tractography for arteriovenous malformations: quantitative analyses to evaluate the corticospinal tract and optic radiation. AJNR Am J Neuroradiol. 2007;28(6):1107–13.
Latchaw RE, et al. Functional magnetic resonance imaging as a management tool for cerebral arteriovenous malformations. Neurosurgery. 1995;37(4):619–25. Discussion 625–6.
Yu C, et al. Study of magnetic resonance imaging-based arteriovenous malformation delineation without conventional angiography. Neurosurgery. 2004;54(5):1104. Discussion 1108–10.
Arteriovenous malformations of the brain in adults. N Engl J Med. 1999;340(23):1812–8.
Barr JD, Mathis JM, Horton JA. Provocative pharmacologic testing during arterial embolization. Neurosurg Clin N Am. 1994;5(3):403–11.
Feliciano CE, et al. Provocative test with propofol: experience in patients with cerebral arteriovenous malformations who underwent neuroendovascular procedures. AJNR Am J Neuroradiol. 2010;31(3):470–5.
Cloft HJ, Joseph GJ, Dion JE. Risk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation: a meta-analysis. Stroke. 1999;30(2):317–20.
Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65(4):476–83.
Hamilton MG, Spetzler RF. The prospective application of a grading system for arteriovenous malformations. Neurosurgery. 1994;34(1):2–6. Discussion 6–7.
Hartmann A, et al. Determinants of neurological outcome after surgery for brain arteriovenous malformation. Stroke. 2000;31(10):2361–4.
Heros RC, Korosue K, Diebold PM. Surgical excision of cerebral arteriovenous malformations: late results. Neurosurgery. 1990;26(4):570–7. Discussion 577–8.
Morgan MK, et al. Surgery for cerebral arteriovenous malformation: risks related to lenticulostriate arterial supply. J Neurosurg. 1997;86(5):801–5.
Morgan MK, et al. Surgical risks associated with the management of Grade I and II brain arteriovenous malformations. Neurosurgery. 2004;54(4):832–7. Discussion 837–9.
Pikus HJ, Beach ML, Harbaugh RE. Microsurgical treatment of arteriovenous malformations: analysis and comparison with stereotactic radiosurgery. J Neurosurg. 1998;88(4):641–6.
Spears J, et al. A discriminative prediction model of neurological outcome for patients undergoing surgery of brain arteriovenous malformations. Stroke. 2006;37(6):1457–64.
Lawton MT. Spetzler-Martin Grade III arteriovenous malformations: surgical results and a modification of the grading scale. Neurosurgery. 2003;52(4):740–8. Discussion 748–9.
Ponce FA, Spetzler RF. Arteriovenous malformations: classification to cure. Clin Neurosurg. 2011;58:10–2.
Spetzler RF, Ponce FA. A 3-tier classification of cerebral arteriovenous malformations. Clinical article. J Neurosurg. 2011;114(3):842–9.
Hashimoto N, et al. Surgery of cerebral arteriovenous malformations. Neurosurgery. 2007;61(1 Suppl):375–87. Discussion 387–9.
Ashley Jr WW, Charbel FT, Amin-Hanjani S. Surgical management of acute intracranial hemorrhage, surgical aneurysmal and arteriovenous malformation ablation, and other surgical principles. Neurol Clin. 2008;26(4):987–1005.
Pavesi G, et al. Acute surgical removal of low-grade (Spetzler-Martin I-II) bleeding arteriovenous malformations. Surg Neurol. 2009;72(6):662–7.
Russell SM, et al. Role of frameless stereotaxy in the surgical treatment of cerebral arteriovenous malformations: technique and outcomes in a controlled study of 44 consecutive patients. Neurosurgery. 2002;51(5):1108–16. Discussion 1116–8.
Killory BD, et al. Prospective evaluation of surgical microscope-integrated intraoperative near-infrared indocyanine green angiography during cerebral arteriovenous malformation surgery. Neurosurgery. 2009;65(3):456–62. Discussion 462.
Fournier D, et al. Endovascular treatment of intracerebral arteriovenous malformations: experience in 49 cases. J Neurosurg. 1991;75(2):228–33.
Mounayer C, et al. Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol. 2007;28(3):518–23.
Valavanis A, Yasargil MG. The endovascular treatment of brain arteriovenous malformations. Adv Tech Stand Neurosurg. 1998;24:131–214.
Spetzler RF, et al. Normal perfusion pressure breakthrough theory. Clin Neurosurg. 1978;25:651–72.
Ledezma CJ, et al. Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors. Neurosurgery. 2006;58(4):602–11. Discussion 602–11.
Sasaki T, et al. Arteriovenous malformations in the basal ganglia and thalamus: management and results in 101 cases. J Neurosurg. 1998;88(2):285–92.
Uno M, et al. Does multimodality therapy of arteriovenous malformations improve patient outcome? Neurol Res. 2004;26(1):50–4.
Chang SD, et al. Multimodality treatment of giant intracranial arteriovenous malformations. Neurosurgery. 2007;61(1 Suppl):432–42. Discussion 442–4.
Gailloud P. Endovascular treatment of cerebral arteriovenous malformations. Tech Vasc Interv Radiol. 2005;8(3):118–28.
Marks MP, et al. Endovascular treatment of cerebral arteriovenous malformations following radiosurgery. AJNR Am J Neuroradiol. 1993;14(2):297–303. Discussion 304–5.
Le Feuvre D, Taylor A. Target embolization of AVMs: identification of sites and results of treatment. Interv Neuroradiol. 2007;13(4):389–94.
Jafar JJ, et al. The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg. 1993;78(1):60–9.
Spetzler RF, et al. Surgical management of large AVM’s by staged embolization and operative excision. J Neurosurg. 1987;67(1):17–28.
Ogilvy CS, et al. Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Circulation. 2001;103(21):2644–57.
Vinuela F, et al. Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases. J Neurosurg. 1991;75(6):856–64.
Mathis JA, et al. The efficacy of particulate embolization combined with stereotactic radiosurgery for treatment of large arteriovenous malformations of the brain. AJNR Am J Neuroradiol. 1995;16(2):299–306.
Gobin YP, et al. Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg. 1996;85(1):19–28.
Friedman WA, et al. Analysis of factors predictive of success or complications in arteriovenous malformation radiosurgery. Neurosurgery. 2003;52(2):296–307. Discussion 307–8.
Kwon Y, et al. Analysis of the causes of treatment failure in gamma knife radiosurgery for intracranial arteriovenous malformations. J Neurosurg. 2000;93 Suppl 3:104–6.
Yu SC, et al. Complete obliteration of intracranial arteriovenous malformation with endovascular cyanoacrylate embolization: initial success and rate of permanent cure. AJNR Am J Neuroradiol. 2004;25(7):1139–43.
Katsaridis V, Papagiannaki C, Aimar E. Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology. 2008;50(7):589–97.
Wikholm G, Lundqvist C, Svendsen P. Embolization of cerebral arteriovenous malformations: Part I – Technique, morphology, and complications. Neurosurgery. 1996;39(3):448–57. Discussion 457–9.
Kusske JA, Kelly WA. Embolization and reduction of the “steal” syndrome in cerebral arteriovenous malformations. J Neurosurg. 1974;40(3):313–21.
Han PP, Ponce FA, Spetzler RF. Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: natural history and treatment paradigm. J Neurosurg. 2003;98(1):3–7.
Miyamoto S, et al. Posttreatment sequelae of palliatively treated cerebral arteriovenous malformations. Neurosurgery. 2000;46(3):589–94. Discussion 594–5.
Sorimachi T, et al. Embolization of cerebral arteriovenous malformations achieved with polyvinyl alcohol particles: angiographic reappearance and complications. AJNR Am J Neuroradiol. 1999;20(7):1323–8.
Song JK, et al. Preoperative embolization of cerebral arteriovenous malformations with silk sutures: analysis and clinical correlation of complications revealed on computerized tomography scanning. J Neurosurg. 2000;92(6):955–60.
Fournier D, et al. Revascularization of brain arteriovenous malformations after embolization with bucrylate. Neuroradiology. 1990;32(6):497–501.
Miyachi S, et al. Embolization of arteriovenous malformations prior to radiosurgery. Interv Neuroradiol. 2000;6 Suppl 1:131–7.
Gruber A, et al. Repermeation of partially embolized cerebral arteriovenous malformations: a clinical, radiologic, and histologic study. AJNR Am J Neuroradiol. 1996;17(7):1323–31.
Wikholm G. Occlusion of cerebral arteriovenous malformations with N-butyl cyano-acrylate is permanent. AJNR Am J Neuroradiol. 1995;16(3):479–82.
Brothers MF, et al. n-Butyl 2-cyanoacrylate – substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies. AJNR Am J Neuroradiol. 1989;10(4):777–86.
Ayad M, Eskioglu E, Mericle RA. Onyx: a unique neuroembolic agent. Expert Rev Med Devices. 2006;3(6):705–15.
Murayama Y, et al. Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery. 1998; 43(5):1164–75.
Chaloupka JC, et al. A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. AJNR Am J Neuroradiol. 1999;20(3):401–10.
Loh Y, Duckwiler GR, Onyx I. Trial, A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg. 2010;113(4):733–41.
Akin ED, Perkins E, Ross IB. Surgical handling characteristics of an ethylene vinyl alcohol copolymer compared with N-butyl cyanoacrylate used for embolization of vessels in an arteriovenous malformation resection model in swine. J Neurosurg. 2003;98(2):366–70.
Velat GJ, et al. Comparison of N-butyl cyanoacrylate and onyx for the embolization of intracranial arteriovenous malformations: analysis of fluoroscopy and procedure times. Neurosurgery. 2008;63(1 Suppl 1):ONS73–8. Discussion ONS78–80.
Natarajan SK, et al. Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx: single-center experience and technical nuances. Neurosurgery. 2008;62(6):1213–25. Discussion 1225–6.
Piotin M, et al. Intracranial arterial aneurysms associated with arteriovenous malformations: endovascular treatment. Radiology. 2001;220(2):506–13.
Meisel HJ, et al. Cerebral arteriovenous malformations and associated aneurysms: analysis of 305 cases from a series of 662 patients. Neurosurgery. 2000;46(4):793–800. Discussion 800–2.
Thompson RC, et al. The management of patients with arteriovenous malformations and associated intracranial aneurysms. Neurosurgery. 1998;43(2):202–11. Discussion 211–2.
Turjman F, et al. Aneurysms related to cerebral arteriovenous malformations: superselective angiographic assessment in 58 patients. AJNR Am J Neuroradiol. 1994;15(9):1601–5.
Kim EJ, et al. The relationship of coexisting extranidal aneurysms to intracranial hemorrhage in patients harboring brain arteriovenous malformations. Neurosurgery. 2004;54(6):1349–57. Discussion 1357–8.
Redekop G, et al. Arterial aneurysms associated with cerebral arteriovenous malformations: classification, incidence, and risk of hemorrhage. J Neurosurg. 1998;89(4):539–46.
Batjer H, Suss RA, Samson D. Intracranial arteriovenous malformations associated with aneurysms. Neurosurgery. 1986;18(1):29–35.
Hartmann A, et al. Risk of endovascular treatment of brain arteriovenous malformations. Stroke. 2002;33(7):1816–20.
Groden C, et al. Two-step presurgical endovascular treatment of five arteriovenous malformations partially fed by single vessels en passage. Surg Neurol. 1999;52(2):160–5. Discussion 165–6.
Hayashi K, et al. [A case of cerebral arteriovenous malformation complicated with intracerebral hemorrhage after endovascular embolization]. No Shinkei Geka. 2001;29(4):353–8.
Jayaraman MV, et al. Neurologic complications of arteriovenous malformation embolization using liquid embolic agents. AJNR Am J Neuroradiol. 2008;29(2):242–6.
Taylor CL, et al. Complications of preoperative embolization of cerebral arteriovenous malformations. J Neurosurg. 2004;100(5):810–2.
Lasak JM, Gorecki JP. The history of stereotactic radiosurgery and radiotherapy. Otolaryngol Clin North Am. 2009;42(4):593–9.
Schneider BF, Eberhard DA, Steiner LE. Histopathology of arteriovenous malformations after gamma knife radiosurgery. J Neurosurg. 1997;87(3):352–7.
Karlsson B, Lindquist C, Steiner L. Prediction of obliteration after gamma knife surgery for cerebral arteriovenous malformations. Neurosurgery. 1997;40(3):425–30. Discussion 430–1.
Maruyama K, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med. 2005;352(2):146–53.
Yen CP, et al. Hemorrhage risk of cerebral arteriovenous malformations before and during the latency period after GAMMA knife radiosurgery. Stroke. 2011;42(6):1691–6.
Yang SY, et al. Radiosurgery for unruptured cerebral arteriovenous malformations: long-term seizure outcome. Neurology. 2012;78(17):1292–8.
Kano H, et al. Stereotactic radiosurgery for arteriovenous malformations, Part 1: management of Spetzler-Martin Grade I and II arteriovenous malformations. J Neurosurg. 2012;116(1):11–20.
Steiner L, et al. Clinical outcome of radiosurgery for cerebral arteriovenous malformations. J Neurosurg. 1992;77(1):1–8.
Nagy G, et al. Stereotactic radiosurgery for arteriovenous malformations located in deep critical regions. Neurosurgery. 2012;70(6):1458–69.
Kurita H, et al. Results of radiosurgery for brain stem arteriovenous malformations. J Neurol Neurosurg Psychiatry. 2000;68(5):563–70.
Kano H, et al. Stereotactic radiosurgery for arteriovenous malformations, Part 4: management of basal ganglia and thalamus arteriovenous malformations. J Neurosurg. 2012;116(1):33–43.
Amponsah K, et al. Staged gamma knife radiosurgery for large cerebral arteriovenous malformations. Stereotact Funct Neurosurg. 2011;89(6):365–71.
Murray G, Brau RH. A 10-year experience of radiosurgical treatment for cerebral arteriovenous malformations: a perspective from a series with large malformations. Clinical article. J Neurosurg. 2011;115(2):337–46.
Karlsson B, Lax I, Soderman M. Risk for hemorrhage during the 2-year latency period following gamma knife radiosurgery for arteriovenous malformations. Int J Radiat Oncol Biol Phys. 2001;49(4):1045–51.
Maruyama K, et al. Radiosurgery to reduce the risk of first hemorrhage from brain arteriovenous malformations. Neurosurgery. 2007;60(3):453–8. Discussion 458–9.
Pollock BE, et al. Factors that predict the bleeding risk of cerebral arteriovenous malformations. Stroke. 1996;27(1):1–6.
Friedman WA, Bova FJ, Mendenhall WM. Linear accelerator radiosurgery for arteriovenous malformations: the relationship of size to outcome. J Neurosurg. 1995;82(2):180–9.
Pollock BE, et al. Factors associated with successful arteriovenous malformation radiosurgery. Neurosurgery. 1998;42(6):1239–44. Discussion 1244–7.
Lunsford LD, et al. Stereotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg. 1991;75(4):512–24.
Kano H, et al. Stereotactic radiosurgery for arteriovenous malformations, Part 6: multistaged volumetric management of large arteriovenous malformations. J Neurosurg. 2012;116(1):54–65.
Pollock BE, et al. Magnetic resonance imaging: an accurate method to evaluate arteriovenous malformations after stereotactic radiosurgery. J Neurosurg. 1996;85(6):1044–9.
Gauvrit JY, et al. Three-dimensional dynamic magnetic resonance angiography for the evaluation of radiosurgically treated cerebral arteriovenous malformations. Eur Radiol. 2006;16(3):583–91.
Flickinger JC, et al. A multi-institutional analysis of complication outcomes after arteriovenous malformation radiosurgery. Int J Radiat Oncol Biol Phys. 1999;44(1):67–74.
Flickinger JC, et al. Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group. Int J Radiat Oncol Biol Phys. 2000;46(5):1143–8.
Flickinger JC, et al. Analysis of neurological sequelae from radiosurgery of arteriovenous malformations: how location affects outcome. Int J Radiat Oncol Biol Phys. 1998;40(2):273–8.
Lindqvist M, et al. Angiographic long-term follow-up data for arteriovenous malformations previously proven to be obliterated after gamma knife radiosurgery. Neurosurgery. 2000;46(4):803–8. Discussion 809–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Razak, A., Hussain, S.I., Kemp, J., Coppens, J.R. (2015). Arteriovenous Malformations of the Brain. In: Edgell, R., Savitz, S., Dalfino, J. (eds) Neurointervention in the Medical Specialties. Current Clinical Neurology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1942-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1942-0_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1941-3
Online ISBN: 978-1-4939-1942-0
eBook Packages: MedicineMedicine (R0)